Equities

OraSure Technologies Inc

OraSure Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)4.69
  • Today's Change-0.150 / -3.10%
  • Shares traded906.21k
  • 1 Year change-14.73%
  • Beta0.1100
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

  • Revenue in USD (TTM)304.64m
  • Net income in USD22.85m
  • Incorporated2000
  • Employees638.00
  • Location
    OraSure Technologies Inc220 E First StBETHLEHEM 18015United StatesUSA
  • Phone+1 (503) 641-6115
  • Fax+1 (610) 882-1830
  • Websitehttps://www.orasure.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ADC Therapeutics SA68.62m-227.23m340.51m273.00------4.96-2.77-2.770.8368-2.350.17690.26832.91251,351.60-56.99-48.41-69.99-55.6393.30---322.09-308.624.35-4.141.85---66.86127.56-52.78--5.42--
C4 Therapeutics Inc20.04m-126.07m340.59m145.00--1.32--17.00-2.37-2.370.36773.760.0504--2.84138,179.30-31.74-25.91-36.02-29.45-----629.24-292.35----0.00---33.251.40-3.37---8.68--
Replimune Group Inc0.00-215.79m341.47m331.00--0.9118-----3.24-3.240.006.100.00----0.00-38.05-29.08-40.71-30.56------------0.1593-------23.82--16.84--
Foghorn Therapeutics Inc.33.90m-92.95m343.04m116.00------10.12-2.21-2.210.8046-2.290.108----292,206.90-29.61-31.35-35.75-35.69-----274.23-777.33--------77.63--9.60---4.50--
Cerus Corp191.72m-31.56m349.44m288.00--7.08--1.82-0.1742-0.17421.060.26710.96231.928.03665,680.60-15.91-25.99-24.20-40.6261.7361.90-16.53-35.811.72-2.160.6287---0.806119.6912.37--32.07--
Emergent Biosolutions Inc1.19bn-565.30m349.52m1.60k--0.5265--0.2949-10.87-10.8722.8612.670.49881.996.09740,875.00-23.79-2.94-38.89-3.6641.1953.24-47.69-5.950.55380.06360.5771---6.106.05-259.40---4.29--
enGene Holdings Inc0.00-106.80m350.60m33.00--2.96-----4.60-4.600.002.69------0.00-------------------1.370.2653-------260.87------
Organogenesis Holdings Inc435.47m5.82m351.32m862.0060.951.2616.550.80680.04350.04353.282.110.96284.084.63505,190.301.295.461.566.9075.0774.941.344.812.418.780.19550.00-3.9417.49-68.16--67.34--
Shattuck Labs Inc2.72m-85.08m351.40m75.00--2.73--129.43-1.93-1.930.06082.710.0168----36,200.00-52.52-29.14-57.94-32.42-----3,133.63-565.33----0.00--154.14-40.6214.37---19.15--
Anavex Life Sciences Corp0.00-40.59m352.11m40.00--2.58-----0.4962-0.49620.001.610.00----0.00-26.73-40.04-28.98-43.97------------0.00------0.9857------
Tourmaline Bio Inc0.00-32.94m356.74m44.00--1.01-----5.35-5.350.0013.810.00----0.00-12.39---12.75--------------0.00------42.99------
OraSure Technologies, Inc.304.64m22.85m357.22m638.0015.890.83818.341.170.3040.3044.115.760.65732.774.31477,493.704.930.72385.420.821245.2646.947.501.1310.49--0.00170.004.6417.41413.1782.2010.18--
Xeris Biopharma Holdings Inc171.36m-64.40m360.26m377.00------2.10-0.4648-0.46481.24-0.06190.52090.8385.02454,525.20-19.58-43.60-25.58-56.5782.9078.23-37.58-143.081.81-2.041.04--48.68131.5034.23--8.43--
Agenus Inc161.42m-239.61m368.96m389.00------2.29-12.68-12.688.49-9.590.4823--170.54414,951.20-74.69-55.02-242.74-115.3199.43---154.88-102.92---1.25----59.4733.56-11.66--22.58--
Ventyx Biosciences Inc0.00-192.60m372.24m74.00--1.21-----3.24-3.240.004.350.00----0.00-53.41---55.81--------------0.00-------77.97------
Aura Biosciences Inc0.00-78.65m372.57m88.00--1.78-----1.86-1.860.004.220.00----0.00-35.66---37.16--------------0.00-------30.03------
Data as of Jun 07 2024. Currency figures normalised to OraSure Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

53.39%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 202411.06m14.98%
The Vanguard Group, Inc.as of 31 Mar 20245.29m7.17%
Dimensional Fund Advisors LPas of 31 Mar 20244.52m6.13%
Camber Capital Management LPas of 31 Mar 20244.25m5.76%
Neuberger Berman Investment Advisers LLCas of 31 Mar 20244.06m5.50%
SSgA Funds Management, Inc.as of 31 Mar 20243.16m4.28%
Cannell Capital LLCas of 31 Mar 20241.93m2.61%
Renaissance Technologies LLCas of 31 Mar 20241.90m2.57%
Geode Capital Management LLCas of 31 Mar 20241.65m2.23%
Acadian Asset Management LLCas of 31 Mar 20241.59m2.16%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.